Problems of reporting genetic associations with complex outcomes

Lancet

Volumn 361, Issue 9360, 2003, Pages 865-872

  Colhoun, Helen M ^a   McKeigue, Paul M ^b   Smith, George Davey ^c  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; CLASSIFICATION; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; INFORMATION PROCESSING; MEDICAL RESEARCH; POPULATION STRUCTURE; PRIORITY JOURNAL; PUBLICATION; REVIEW; SAMPLE SIZE;

EID: 0037426052     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12715-8     Document Type: Review

References (58)

1. Ioannidis J.P., Ntzani E.E., Trikalinos T.A., Contopoulos-Ioannidis D.G. Replication validity of genetic association studies. Nat Genet. 29:2001;306-309.
2. Dahlman I., Eaves I.A., Kosoy R., et al. Parameters for reliable results in genetic association studies in common disease. Nat Genet. 30:2002;149-150.
3. Editorial. Freely associating. Nat Genet 1999; 22: 1-2.
4. Cusi D., Barlassina C., Azzani T., et al. Polymorphisms of alpha-adducin and salt sensitivity in patients with essential hypertension. Lancet. 349:1997;1353-1357.
5. Casari G., Barlassina C., Cusi D., et al. Association of the alpha-adducin locus with essential hypertension. Hypertension. 25:1995;320-326.
6. Castellano M., Barlassina C., Muiesan M.L., et al. Alpha-adducin gene polymorphism and cardiovascular phenotypes in a general population. J Hypertens. 15:1997;1707-1710.
7. Kamitani A., Wong Z.Y., Fraser R., et al. Human alpha-adducin gene, blood pressure, and sodium metabolism. Hypertension. 32:1998;138-143.
8. Ishikawa K., Katsuya T., Sato N., et al. No association between alpha-adducin 460 polymorphism and essential hypertension in a Japanese population. Am J Hypertens. 11:1998;502-506.
9. Kato N., Sugiyama T., Nabika T., et al. Lack of association between the alpha-adducin locus and essential hypertension in the Japanese population. Hypertension. 31:1998;730-733.
10. Schork N.J., Chakravarti A., Thiel B., et al. Lack of association between a biallelic polymorphism in the adducin gene and blood pressure in whites and African Americans. Am J Hypertens. 13:2000;693-698.
11. Bray M.S., Li L., Turner S.T., Kardia S.L., Boerwinkle E. Association and linkage analysis of the alpha-adducin gene and blood pressure. Am J Hypertens. 13:2000;699-703.
12. Ranade K., Hsuing A.C., Wu K.D., et al. Lack of evidence for an association between alpha-adducin and blood pressure regulation in Asian populations. Am J Hypertens. 13:2000;704-709.
13. Boerwinkle E. All for one and one for all: introduction to a coordinated analysis of the Gly-460-Trp alpha-adducin polymorphism. Am J Hypertens. 13:2000;734-735.
14. Cardon L.R., Bell J.I. Association study designs for complex diseases. Nat Rev Genet. 2:2001;91-99.
15. Gambaro G., Anglani F., D'Angelo A. Association studies of genetic polymorphisms and complex disease. Lancet. 355:2000;308-311.
16. Strohman R. Maneuvering in the complex path from genotype to phenotype. Science. 296:2002;701-703.
17. Holtzman N.A. Putting the search for genes in perspective. Int J Health Serv. 31:2001;445-461.
18. Collins A., MacLean C.J., Morton N.E. Trials of the beta model for complex inheritance. Proc Natl Acad Sci USA. 93:1996;9177-9181.
19. Terwilliger J.D., Weiss K.M. Linkage disequilibrium mapping of complex disease: fantasy or reality? Curr Opin Biotechnol. 9:1998;578-594.
20. Reich D.E., Lander E.S. On the allelic spectrum of human disease. Trends Genet. 17:2001;502-510.
21. Wacholder S., Rothman N., Caporaso N. Counterpoint: bias from population stratification is not a major threat to the validity of conclusions from epidemiological studies of common polymorphisms and cancer. Cancer Epidemiol Biomarkers Prev. 11:2002;513-520.
22. Bianchi G., Cusi D. Association and linkage analysis of alpha-adducin polymorphism: is the glass half full or half empty? Am J Hypertens. 13:2000;739-743.
23. Vieland V.J. The replication requirement. Nat Genet. 29:2001;244-245.
24. Cavalli-Sforza L.L., Menozzi P., Piazza A. The history and geography of human genes. 1994;Princeton University Press, Princeton.
25. Tishkoff S.A., Dietzsch E., Speed W., et al. Global patterns of linkage disequilibrium at the CD4 locus and modern human origins. Science. 271:1996;1380-1387.
26. Reich D.E., Cargill M., Bolk S., et al. Linkage disequilibrium in the human genome. Nature. 411:2001;199-204.
27. Rosenberg N., Murata M., Ikeda Y., et al. The frequent 5,10-methylenetetrahydrofolate reductase C677T polymorphism is associated with a common haplotype in whites, Japanese, and Africans. Am J Hum Genet. 70:2002;758-762.
28. Clayton D., McKeigue P.M. Epidemiological methods for studying genes and environmental factors in complex diseases. Lancet. 358:2001;1356-1360.
29. Thomas D.C., Witte J.S. Point: population stratification - a problem for case-control studies of candidate-gene associations? Cancer Epidemiol Biomarkers Prev. 11:2002;505-512.
30. Morton N.E., Collins A. Tests and estimates of allelic association in complex inheritance. Proc Natl Acad Sci USA. 95:1998;11389-11393.
31. Ardlie K.G., Kruglyak L., Seielstad M. Patterns of linkage disequilibrium in the human genome. Nat Rev Genet. 3:2002;299-309.
32. Little J., Bradley L., Bray M.S., et al. Reporting, appraising, and integrating data on genotype prevalence and gene-disease associations. Am J Epidemiol. 156:2002;300-310.
33. Wacholder S., Rothman N., Caporaso N. Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst. 92:2000;1151-1158.
34. Paris P.L., Kupelian P.A., Hall J.M., et al. Association between a CYP3A4 genetic variant and clinical presentation in African-American prostate cancer patients. Cancer Epidemiol Biomarkers Prev. 8:1999;901-905.
35. Pritchard J.K., Stephens M., Rosenberg N.A., Donnelly P. Association mapping in structured populations. Am J Hum Genet. 67:2000;170-181.
36. Risch N., Merikangas K. The future of genetic studies of complex human diseases. Science. 273:1996;1516-1517.
37. Homocysteine and risk of ischemic heart disease and stroke: a meta-anlysis. JAMA. 288:2002;2015-2022.
38. Klerk M., Verhoef P., Clarke R., et al. MTHFR 677C→T polymorphism and risk of coronary heart disease: a meta-analysis. JAMA. 288:2002;2023-2031.
39. Keavney B., McKenzie C., Parish S., et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. Lancet. 355:2000;434-442.
40. Goring H.H., Terwilliger J.D., Blangero J. Large upward bias in estimation of locus-specific effects from genomewide scans. Am J Hum Genet. 69:2001;1357-1369.
41. Samani N.J., Thompson S.R., O'Toole L., Channer K., Woods K.L. A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation. 94:1996;708-712.
42. Staessen J.A., Wang J.G., Ginocchio G., et al. The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens. 15:1997;1579-1592.
43. Agerholm-Larsen B., Nordestgaard B.G., Tybjaerg-Hansen A. ACE gene polymorphism in cardiovascular disease: meta-analyses of small and large studies in whites. Arterioscler Thromb Vasc Biol. 20:2000;484-492.
44. Egger M., Ebrahim S., Davey Smith G. Where now for meta-analysis? Int J Epidemiol. 31:2002;1-5.
45. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:1997;629-634.
46. Lander E., Kruglyak L. Genetic dissection of complex traits: guidelines for interpreting and reporting linkage results. Nat Genet. 11:1995;241-247.
47. Altshuler D., Kruglyak L., Lander E. Genetic polymorphisms and disease. N Engl J Med. 338:1998;1626.
48. Goodman S.N. values, hypothesis tests, and likelihood: implications for epidemiology of a neglected historical debate. Am J Epidemiol. 137:1993;485-496.
49. Elston R.C. 1996 William Allan Award Address: algorithms and inferences - the challenge of multifactorial diseases. Am J Hum Genet. 60:1997;255-262.
50. Barnardo J.M., Smith A.F.M. Bayesian Theory. 2000;67-69 Wiley, Chichester.
51. Sterne J.A., Davey Smith G. Sifting the evidence: what's wrong with significance tests? BMJ. 322:2001;226-231.
52. Oakes M. Statistical inference. 1986;Wiley, Chichester.
53. Johnson G.C., Esposito L., Barratt B.J., et al. Haplotype tagging for the identification of common disease genes. Nat Genet. 29:2001;233-237.
54. Witte J.S., Elston R.C., Cardon L.R. On the relative sample size required for multiple comparisons. Stat Med. 19:2000;369-372.
55. MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 360:2002;23-33.
56. The Canadian Cochrane Network and Centre. http://www.cochrane.org (accessed Nov 28, 2002).
57. National Center for Biotechnology Information. OMIM: Online Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/Omim (accessed Nov 28, 2002).
58. Human Genome Epidemiology Network. HuGE Net. http://www.cdc.gov/genomics/hugenet (accessed Nov 28, 2002).